Statistics for Neurocrine Biosciences (id:7239 NBIX)
Valuation metrics
Market cap
12.66B
Enterprise value
11.54B
Trailing P/E (ttm)
33.33
Forward P/E
20.13
PEG ratio
20.13
Price/Sales (ttm)
5.64
Price/Book (mrq)
4.65
Enterprise Value/Revenue
5.15
Enterprise Value/EBITDA
18.38
Overview
Shares outstanding
101.25M
Float
100.09M
Shares short
2.48M
% Held by insiders
0.01%
% Held by institutions
0.95%
Average volume (10 days)
1.03M
Average volume (90 days)
Price summary
52-Week low
110.52
52-Week high
157.98
52-Week change
10.09%
Beta
0.35
50-Day moving average
118.48
200-Day moving average
133.47
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
December 29th, 1995
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
17.21%
Operating margin
29.71%
Operational effectiveness
Return on assets
11.80%
Return on equity
16.35%
Income statement
Revenue (ttm)
22.42
Revenue per share (ttm)
22.42
Quarterly revenue growth (yoy)
0.56
Gross profit (ttm)
1.85B
EBITDA
608.50M
Net income to common (ttm)
385.90M
Diluted EPS (ttm)
3.75
Quarterly earnings growth (yoy)
56.20%
Balance sheet
Total cash (mrq)
1.23B
Total cash per share (mrq)
12.13
Total debt (mrq)
286.20M
Total Debt/Equity (mrq)
10.53
Current ratio (mrq)
436.70%
Book value per share (mrq)
26.87
Cash flow
Cash flow statement
476.40M
Levered free cash flow (LFCF)
328.06M